Danaher DHR
NYSE DHR
$212.54 +4.18 (+2.01%)
As of: Sep 17, 2026 · 3:59 PM EDT

Danaher (DHR) Non-Current Assets (2009 - 2026)

Danaher (DHR) posted Non-Current Assets of $79.0 billion for Q2 2026, up 13.47% on a QoQ basis from $69.6 billion in Q1 2026, and up 11.84% year-over-year from $70.6 billion in Q2 2025.

Analysis

Danaher (DHR) Non-Current Assets (2009 - 2026) Analysis & Trends

Danaher has reported Non-Current Assets for 18 years, with the latest figure at $79.0 billion in Q2 2026.

  • On a quarterly basis, Non-Current Assets rose 11.84% year-over-year to $79.0 billion in Q2 2026; TTM through Jun 2026 was $289.6 billion, a 3.87% increase from a year earlier, with the FY2025 full-year figure at $70.7 billion, up 3.91% from the prior year.
  • Non-Current Assets was $79.0 billion for Q2 2026 at Danaher, up from $69.6 billion in the prior quarter.
  • The five-year high for Non-Current Assets was $79.0 billion in Q2 2026, with the low at $66.5 billion in Q3 2023.
  • Average Non-Current Assets over 5 years is $69.7 billion, with a median of $69.3 billion recorded in 2024.
  • The largest YoY upside for Non-Current Assets was 15.16% in 2022 against a maximum downside of 6.89% in 2022.
  • Over 5 years, Non-Current Assets stood at $68.5 billion in 2022, then grew by 3.04% to $70.6 billion in 2023, then fell by 3.55% to $68.0 billion in 2024, then increased by 3.91% to $70.7 billion in 2025, then climbed by 11.71% to $79.0 billion in 2026.
  • The last three Non-Current Assets figures came in at $79.0 billion (Q2 2026), $69.6 billion (Q1 2026), and $70.7 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn 89.81 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn 78.99 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 9.27 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 3.82 Bn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn 9.75 Bn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 1.84 Bn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn 7.23 Bn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 1.75 Bn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 355.40 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn 3.83 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 26, 2026 78.99 Bn
Mar 27, 2026 69.61 Bn
Dec 31, 2025 70.71 Bn
Sep 26, 2025 70.29 Bn
Jun 27, 2025 70.62 Bn
Mar 28, 2025 69.59 Bn
Dec 31, 2024 68.05 Bn
Sep 27, 2024 70.56 Bn
Jun 28, 2024 68.95 Bn
Mar 29, 2024 69.03 Bn
Dec 31, 2023 70.55 Bn
Sep 29, 2023 66.53 Bn
Jun 30, 2023 67.44 Bn
Mar 31, 2023 68.51 Bn
Dec 31, 2022 68.47 Bn
Sep 30, 2022 66.78 Bn
Jul 1, 2022 68.58 Bn
Apr 1, 2022 70.72 Bn
Dec 31, 2021 71.54 Bn
Oct 1, 2021 71.72 Bn